Steven A. Shallcross - Jan 20, 2023 Form 4 Insider Report for Theriva Biologics, Inc. (TOVX)

Role
CEO and CFO, Director
Signature
/s/ Steven A. Shallcross
Stock symbol
TOVX
Transactions as of
Jan 20, 2023
Transactions value $
$18,705
Form type
4
Date filed
1/23/2023, 05:08 AM
Previous filing
Jan 3, 2023
Next filing
Jan 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOVX Common Stock Purchase $18.7K +25K +22.73% $0.75 135K Jan 20, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.